Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other financing activities (2018 - 2020)

Standard Biotools (LAB) has disclosed Other financing activities for 3 consecutive years, with $18000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Other financing activities rose 20.0% to $18000.0 in Q2 2020 year-over-year; TTM through Jun 2021 was $375000.0, a 25.45% decrease, with the full-year FY2022 number at $12.5 million, changed N/A from a year prior.
  • Other financing activities was $18000.0 for Q2 2020 at Standard Biotools, down from $357000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.6 million in Q2 2018 to a low of $15000.0 in Q2 2019.
  • A 3-year average of $420625.0 and a median of $98000.0 in 2018 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: crashed 99.41% in 2019, then grew 20.0% in 2020.
  • Standard Biotools' Other financing activities stood at $83000.0 in 2018, then surged by 36.14% to $113000.0 in 2019, then tumbled by 84.07% to $18000.0 in 2020.
  • Per Business Quant, the three most recent readings for LAB's Other financing activities are $18000.0 (Q2 2020), $357000.0 (Q1 2020), and $113000.0 (Q3 2019).